People with Huntington’s disease have greater variations in disease symptoms and physical function between days than within each day,…
Articles by Andrea Lobo
Wave Life Sciences is making plans to launch a potentially pivotal Phase 2/3 clinical trial in the U.S. to…
The European Medicines Agency (EMA) has agreed to review Prilenia Therapeutics’ application seeking approval of pridopidine, an oral…
People with Huntington’s disease have significantly higher levels of the proinflammatory molecule interleukin-6 (IL-6) and the anti-inflammatory molecule IL-10…
Nonprofits around the world are hoping to “turn up the global volume” for Huntington’s Disease Awareness Month, an annual…